Creosote Combination

Product NDC
63083-9254
11-digit product format
630839254
Labeler code
63083
Product ID
63083-9254_9efdecb8-b860-4856-917e-c8b2302a817c
Type
HUMAN OTC DRUG
Nonproprietary name
Creosote Combination
Dosage form
LIQUID
Route
ORAL
Labeler
Professional Complementary Health Formulas
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
1984-08-15
Substance
ACONITUM NAPELLUS WHOLE; AMARYLLIS BELLADONNA WHOLE; ANTIMONY POTASSIUM TARTRATE; BRYONIA ALBA ROOT; CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED; HYOSCYAMUS NIGER; IPECAC; LOBARIA PULMONARIA; LOBELIA INFLATA WHOLE; PHOSPHORUS; SILICON DIOXIDE; WOOD CREOSOTE
Active strength
4; 4; 6; 4; 30; 30; 4; 4; 4; 4; 5; 6; 6 [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL; [hp_X]/29.5mL
Pharmacologic classes
Actively Acquired Immunity [PE], Inactivated Clostridium Tetani Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Creosote Combination
Brand name suffix
9254
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ACONITUM NAPELLUS WHOLE4 [hp_X]/29.5mL
AMARYLLIS BELLADONNA WHOLE4 [hp_X]/29.5mL
ANTIMONY POTASSIUM TARTRATE6 [hp_X]/29.5mL
BRYONIA ALBA ROOT4 [hp_X]/29.5mL
CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)30 [hp_X]/29.5mL
HUMAN SPUTUM, BORDETELLA PERTUSSIS INFECTED30 [hp_X]/29.5mL
HYOSCYAMUS NIGER4 [hp_X]/29.5mL
IPECAC4 [hp_X]/29.5mL
LOBARIA PULMONARIA4 [hp_X]/29.5mL
LOBELIA INFLATA WHOLE4 [hp_X]/29.5mL
PHOSPHORUS5 [hp_X]/29.5mL
SILICON DIOXIDE6 [hp_X]/29.5mL
WOOD CREOSOTE6 [hp_X]/29.5mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiU0NQ8555JD, 11B89M58UN, DL6OZ476V3, T7J046YI2B, K3W1N8YP13, U364V64HUN, 4WRK2153H3, 62I3C8233L, D1YM0P5Z2T, 9PP1T3TC5U, 27YLU75U4W, ETJ7Z6XBU4, 3JYG22FD73

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63083-9254-12026-01-09C16284748780-11030e365-578c-111a-e063-dadaa90a10e2R254
63083-9254-12026-01-09C16284748780-11030e365-578c-111a-e063-dadaa90a10e2R254
63083-9254-12024-01-30C16284748780-11030e365-578c-111a-e063-dadaa90a10e2R254
63083-9254-12024-01-30C16284748780-11030e365-578c-111a-e063-dadaa90a10e2R254

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
63083-9254-1Creosote Combination925429.5 mL in 1 BOTTLE, DROPPERLIQUID29.52

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
63083-9254CREOSOTE COMBINATION 9254 (CREOSOTE COMBINATION) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]1Current NDC, Legacy NDC, 1 package rows20220210_9248c4d5-75a5-4b52-b6b1-b2b8af8da827.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
63083-9254-16308392540129.5 mL in 1 BOTTLE, DROPPER (63083-9254-1) 29.5 ml1985-08-150000-00-00NoNoCurrent